4//SEC Filing
Moukheibir Catherine 4
Accession 0000950170-24-071393
CIK 0001446847other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:58 PM ET
Size
6.9 KB
Accession
0000950170-24-071393
Insider Transaction Report
Form 4
Moukheibir Catherine
Director
Transactions
- Sale
Class A Common Stock
2024-06-06$6.36/sh−44,426$282,549→ 84,207 total - Sale
Class A Common Stock
2024-06-07$6.61/sh−35,574$235,144→ 48,633 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.56 to $6.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001772130
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:58 PM ET
- Size
- 6.9 KB